These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

123 related items for PubMed ID: 1734586

  • 1. Irradiated volume and arytenoid edema after radiotherapy for T1 glottic carcinoma.
    Inoue T, Inoue T, Chatani M, Teshima T.
    Strahlenther Onkol; 1992 Jan; 168(1):23-6. PubMed ID: 1734586
    [Abstract] [Full Text] [Related]

  • 2. Radiation therapy for early glottic carcinoma (T1N0M0). The final results of prospective randomized study concerning radiation field.
    Chatani M, Matayoski Y, Masaki N, Teshima T, Inoue To.
    Strahlenther Onkol; 1996 Mar; 172(3):169-72. PubMed ID: 8721266
    [Abstract] [Full Text] [Related]

  • 3. Radiation therapy for early glottic carcinoma: indication for the wedge filter.
    Chatani M, Matayoshi Y, Masaki N, Inoue T, Teshima T, Inoue T.
    Strahlenther Onkol; 1993 Nov; 169(11):655-9. PubMed ID: 8248841
    [Abstract] [Full Text] [Related]

  • 4. Radiation therapy for larynx carcinoma: long-term results of stage I glottic carcinoma.
    Chatani M, Matayoshi Y, Masaki N.
    Strahlenther Onkol; 1993 Feb; 169(2):102-6. PubMed ID: 8451724
    [Abstract] [Full Text] [Related]

  • 5. Clinical assessment of tumor clearance during radiotherapy as a prognostic factor of early glottic carcinoma.
    Inoue T, Inoue T, Ikeda H, Teshima T, Murayama S.
    Strahlenther Onkol; 1992 Oct; 168(10):579-83. PubMed ID: 1440229
    [Abstract] [Full Text] [Related]

  • 6. Overall time in telecobalt therapy for T1 glottic carcinoma treated with 2 Gy per day.
    Inoue T, Inoue T, Teshima T, Murayama S, Yamazaki H, Nose T, Tanaka E.
    Strahlenther Onkol; 1995 Aug; 171(8):475-7. PubMed ID: 7652672
    [Abstract] [Full Text] [Related]

  • 7. Comparison of early glottic and supraglottic carcinoma treated with conventional fractionation of radiotherapy.
    Inoue T, Inoue T, Ikeda H, Teshima T, Yamazaki H, Murayama S, Othani M, Ozeki S.
    Strahlenther Onkol; 1993 Oct; 169(10):584-9. PubMed ID: 8235982
    [Abstract] [Full Text] [Related]

  • 8. Long-term results of radiotherapy for T1a and T1bN0M0 glottic carcinoma.
    Nomiya T, Nemoto K, Wada H, Takai Y, Yamada S.
    Laryngoscope; 2008 Aug; 118(8):1417-21. PubMed ID: 18528306
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Radiation therapy of T1N0M0 glottic carcinoma: clinical evaluations based on field size, plastic shell and wedge filter].
    Teshima T, Chatani M, Inoue T, Inoue T.
    Gan No Rinsho; 1986 Feb; 32(2):141-6. PubMed ID: 3083145
    [Abstract] [Full Text] [Related]

  • 12. The significance of arytenoid edema following radiotherapy of laryngeal carcinoma with respect to residual and recurrent tumour.
    Ichimura K, Sugasawa M, Nibu K, Takasago E, Hasezawa K.
    Auris Nasus Larynx; 1997 Oct; 24(4):391-7. PubMed ID: 9352832
    [Abstract] [Full Text] [Related]

  • 13. Decreased local control following radiation therapy alone in early-stage glottic carcinoma with anterior commissure extension.
    Zouhair A, Azria D, Coucke P, Matzinger O, Bron L, Moeckli R, Do HP, Mirimanoff RO, Ozsahin M.
    Strahlenther Onkol; 2004 Feb; 180(2):84-90. PubMed ID: 14762660
    [Abstract] [Full Text] [Related]

  • 14. Radiotherapy for patients with early-stage glottic carcinoma: univariate and multivariate analyses in a group of consecutive, unselected patients.
    Franchin G, Minatel E, Gobitti C, Talamini R, Vaccher E, Sartor G, Politi D, Trovò MG, Barzan L.
    Cancer; 2003 Aug 15; 98(4):765-72. PubMed ID: 12910521
    [Abstract] [Full Text] [Related]

  • 15. [Radiotherapy of carcinoma of the larynx--dose and function preservation].
    Nakano M, Iida K, Sato S, Sakata S, Sueyama H.
    Gan No Rinsho; 1985 Sep 15; 31(12):1602-4. PubMed ID: 4079049
    [Abstract] [Full Text] [Related]

  • 16. Radiotherapy for early glottic carcinoma (T1N0M0): results of prospective randomized study of radiation fraction size and overall treatment time.
    Yamazaki H, Nishiyama K, Tanaka E, Koizumi M, Chatani M.
    Int J Radiat Oncol Biol Phys; 2006 Jan 01; 64(1):77-82. PubMed ID: 16169681
    [Abstract] [Full Text] [Related]

  • 17. Results of radiotherapy of carcinoma laryngis in relation to the mode of dose fractionation.
    Durkovský J, Sevcíková L, Miklánková M.
    Neoplasma; 1981 Jan 01; 28(5):599-609. PubMed ID: 7312078
    [Abstract] [Full Text] [Related]

  • 18. Radiotherapy with 6-megavolt photons for early glottic carcinoma: potential impact of extension to the posterior vocal cord.
    Lee JH, Machtay M, McKenna MG, Weinstein GS, Markiewicz DA, Krisch RE, Kligerman MM.
    Am J Otolaryngol; 2001 Jan 01; 22(1):43-54. PubMed ID: 11172214
    [Abstract] [Full Text] [Related]

  • 19. Prognostic factors of glottic carcinomas treated with radiation therapy: value of the adjacent sign on radiological examinations in the sixth edition of the UICC TNM staging system.
    Murakami R, Nishimura R, Baba Y, Furusawa M, Ogata N, Yumoto E, Yamashita Y.
    Int J Radiat Oncol Biol Phys; 2005 Feb 01; 61(2):471-5. PubMed ID: 15667969
    [Abstract] [Full Text] [Related]

  • 20. [Stage 1 glottic laryngeal carcinoma: observations on 76 cases treated with transcutaneous radiotherapy].
    Bonetta A, Morrica B, Zingoni A, Caraffini B.
    Radiol Med; 1996 Jun 01; 91(6):802-4. PubMed ID: 8830370
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.